Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IIa trial of Avonex in rheumatoid arthritis
ISRCTN03626626Phase 3Completed
- Sponsor
- Biogen
- Start
- Jan 2002
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in rheumatoid arthritis (RA) comparing Avonex with Placebo (2 arms). Started Jan 2002; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on ISRCTN03626626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN03626626.